Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis
European Respiratory Journal · 2025
DOI: 10.1183/13993003.01855-2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2025. Verfasst von Felix Ratjen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada felix.ratjen@sickkids.ca. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Epithelial Cells, Nasal Mucosa. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Cystic Fibrosis Canada, Genome Canada, Ontario Genomics Institute.
Abstract (Originalsprache)
Background
In people with cystic fibrosis (pwCF), human nasal epithelial cell (HNEC) cultures can be used to assess response to CF transmembrane conductance regulator (CFTR) modulators. However, thresholds of in vitro responses that predict clinical benefit remain poorly understood. In this study we describe the concordance between in vitro response in HNECs and clinical outcomes in pwCF harbouring the F508del variant, treated with either lumacaftor/ivacaftor, tezacaftor/ivacaftor or elexacaftor/tezacaftor/ivacaftor.
Methods
Response of HNECs to CFTR modulators was assessed by CFTR-mediated chloride current stimulated by forskolin or inhibited by CFTRinh-172 in both pwCF and healthy controls. Clinical response was defined as change in forced expiratory volume in 1 s (FEV 1 ), lung clearance index (LCI), sweat chloride or respiratory domain of the Cystic Fibrosis Questionnaire-Revised (CFQ-R) between baseline and within 3 months after the start of modulator treatment.
Results
In 58 unique in vitro –clinical pairs, in vitro measures of functional rescue correlated with changes in FEV 1 , LCI and sweat chloride, but not CFQ-R. The concordance between in vitro response and clinical outcomes was highest when a composite outcome was used. For example, an in vitro response of 10% of healthy controls had positive and negative predictive values of 90.5% and 100%, respectively, for a clinical response in either FEV 1 , LCI or sweat chloride.
Conclusions
We identified thresholds of nasal epithelial cell theratype response in pwCF to predict clinical benefit from CFTR modulator therapy. The utility of this therapy testing platform to predict a clinical response improves when multiple clinical outcome measures are combined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada felix.ratjen@sickkids.ca.
- Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
- Translational Medicine Program, SickKids Research Institute, Toronto, ON, Canada.
- Department of Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada.
- Molecular Medicine Program, SickKids Research Institute, Toronto, ON, Canada.
- Cystic Fibrosis Canada, Toronto, ON, Canada.
ORCID-Profile: Felix Ratjen, Theo J Moraes
Förderung
- Cystic Fibrosis Canada
- Genome Canada
- Ontario Genomics Institute
- Hospital for Sick Children
Zitieren
APA
Ratjen, F., Stanojevic, S., Gunawardena, T., Eckford, P. D. W., Avolio, J., Shaw, M., Bartlett, C., Ouyang, H., Moraes, T. J., Gonska, T., & Bear, C. (2025). Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis. European Respiratory Journal. https://doi.org/10.1183/13993003.01855-2024
Vancouver
Ratjen F, Stanojevic S, Gunawardena T, Eckford PDW, Avolio J, Shaw M, et al. Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis. European Respiratory Journal. 2025. doi:10.1183/13993003.01855-2024
BibTeX
@article{Ratjen2025,
author = {Ratjen, Felix and Stanojevic, Sanja and Gunawardena, Tarini and Eckford, Paul D W and Avolio, Julie and Shaw, Michelle and Bartlett, Claire and Ouyang, Hong and Moraes, Theo J and Gonska, Tanja and Bear, Christine},
title = {Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis},
journal = {European Respiratory Journal},
year = {2025},
doi = {10.1183/13993003.01855-2024}
}
EUVIMED